Show simple item record

dc.contributor.authorO'Connell, Jean
dc.contributor.authorLynch, Lydia
dc.contributor.authorCawood, Tom J
dc.contributor.authorKwasnik, Anna
dc.contributor.authorNolan, Niamh
dc.contributor.authorGeoghegan, Justin
dc.contributor.authorMcCormick, Aiden
dc.contributor.authorO'Farrelly, Cliona
dc.contributor.authorO'Shea, Donal
dc.date.accessioned2011-10-24T15:17:56Z
dc.date.available2011-10-24T15:17:56Z
dc.date.issued2010
dc.identifier.citationThe relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. 2010, 5 (4):e9997 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid20376319
dc.identifier.doi10.1371/journal.pone.0009997
dc.identifier.urihttp://hdl.handle.net/10147/146584
dc.description.abstractSeveral studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity.
dc.description.abstractThirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71).
dc.description.abstractThere was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis.
dc.description.abstractMetabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.
dc.language.isoenen
dc.subject.meshAdipocytes
dc.subject.meshAdult
dc.subject.meshBody Mass Index
dc.subject.meshCell Size
dc.subject.meshFatty Liver
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInsulin Resistance
dc.subject.meshMale
dc.subject.meshMetabolic Diseases
dc.subject.meshMetabolic Syndrome X
dc.subject.meshMiddle Aged
dc.subject.meshOmentum
dc.subject.meshSubcutaneous Fat
dc.titleThe relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.en
dc.typeArticleen
dc.contributor.departmentObesity Research Group, Education and Research Centre, St Vincent's University Hospital, Dublin, Ireland. jeanoco@gmail.comen
dc.identifier.journalPloS oneen
dc.description.provinceLeinster
refterms.dateFOA2018-08-22T14:49:34Z
html.description.abstractSeveral studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity.
html.description.abstractThirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71).
html.description.abstractThere was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis.
html.description.abstractMetabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.


Files in this item

Thumbnail
Name:
20376319.pdf
Size:
401.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record